<DOC>
	<DOCNO>NCT00985725</DOCNO>
	<brief_summary>To evaluate efficacy SPD489 treatment executive function impairment ( EFI ) use adjunct stable , standard therapy set partial full remission recurrent Major Depressive Disorder ( MDD ) measure Global Executive Composite ( GEC ) T-score Behavioral Rating Inventory Executive Functioning - Adult Version ( BRIEF-A ) .</brief_summary>
	<brief_title>SPD489 Adults With Persistent Executive Function Impairments ( EFI ) Partial Full Remission Recurrent Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Adults age 1855 primary diagnosis nonpsychotic unipolar depression Current comorbid psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Major Depressive Disorder</keyword>
</DOC>